SPONSORS AND MEDIA PARTNERS


































|
ORGANIZING COMMITTEE
- Raj Bawa '90, MS, Ph.D., Bawa Biotechnology Consulting, LLC (Ashburn, VA); Rensselaer Polytechnic Institute (Troy, NY); NVCC (Annandale, VA) Conference Chair
- Kathy Kinsey, Rensselaer Polytechnic Institute (Troy, NY)
- Rubina Nitta, PharmD, Hannaford Food and Drug (Pawling, NY)
- Phyllis Gardner, MD, Stanford University School of Medicine (Stanford, CA)
- Richard W. Siegel, Ph.D., Rensselaer Polytechnic Institute (Troy, NY)
- Clayton Teague, Ph.D., National Nanotechnology Coordination Office (Arlington, VA)
- Donald A. Tomalia, Ph.D., Dendritic Nanotechnologies, Inc. (Ann Arbour, MI)
- Q. Todd Dickenson, JD, General Electric Company (Fairfield, CT)
- S. R. Bawa, MSc, Ph.D, Bawa Biotechnology Consulting, LLC (Schenectady, NY)
- Thomas J. Webster, Ph.D., Brown University Medical School (Providence, RI)
- Stephen B. Maebius, JD, Foley & Lardner LLP (Washington, DC)
- Manoj V. Motwani, MD, Alpha Laser Center (San Diego, CA)
- Chid Iyer, MS, JD, Sughrue Mion PLLC (Washington, DC)
- Tim Mack, JD, MBA, World Future Society (Bethesda, MD)
- Chiming Wei, MD, Ph.D., Johns Hopkins University School of Medicine, (Baltimore, MD)
- Michael L. Weiner, Biophan Technologies, Inc. (West Henrietta, NY)
- Charles Rancourt '70, Rensselaer Polytechnic Institute (Troy, NY)
- Thurman K. Page, MA, JD, US Patent & Trademark Office (Washington, DC)
- Neil Gordon, MBA, Canadian NanoBusiness Alliance (Montreal, Canada)
- Wiwut Tanthapanichakoon, PhD, National Nanotechnology Center (Thailand)
- M. N. V. Ravi Kumar, Ph.D., National Institute of Pharmaceutical Education & Research (India)
CONFERENCE PROGRAM
September 25, 2006 (Monday)
On-site Registration and Media Interviews: 10 - 10:30 a.m.
Conference Chair’s Opening Remarks - 10:30 a.m.
Raj Bawa '90, MS, Ph.D.
President, Bawa Biotechnology Consulting, LLC (Arlington, VA); Advisor/Patent Agent, Rensselaer Polytechnic Institute (Troy, NY); Adjunct Professor of Natural & Applied Sciences, NVCC (Annandale, VA)
Introduction of Nobel Lecturer - 10:35 a.m.
Nobel Lecture - 10:40 a.m. (30 minutes)
“Nanotechnology – A Nobel Laureate’s Perspective”
Ivar Giaever '64, Ph.D.
Nobel Laureate;
Founder, Applied BioPhysics, Inc. (Troy, NY)
Session #1 - 11:20 a.m. (90 minutes)
R&D Innovations in Nanoscience and Nanotechnology
Speakers:
“What is Nanotechnology? - A Guided Pictorial Tour”
Raj Bawa '90, MS, Ph.D.
President, Bawa Biotechnology Consulting, LLC (Ashburn, VA and Schenectady, NY);
Advisor/Patent Agent, Rensselaer Polytechnic Institute (Troy, NY);
Adjunct Professor, NVCC (Annandale, VA)
“Nano Neuro Knitting”
Rutledge Ellis-Behnke, Ph.D.
Principle Investigator, Department of Brain & Cognitive Sciences, Massachusetts Institute of Technology (Cambridge, MA);
Principle Investigator, Department of Anatomy,
University of Hong Kong Li Ka Shing Faculty of Medicine (Hong Kong SAR, China)
"Recent Advances in Nanotechnology for Cancer"
Linda K. Molnar, Ph.D.
Project Officer, National Cancer Institute (Bethesda, MD); Program Manager, SAIC,
Center for Advanced Materials and Nanotechnology (Bethesda, MD)
“Nanotechnology for Defense”
Sharon L. Smith, Ph.D.
Director, Advanced Technology, Lockheed Martin Corporation (Bethesda, MD)
“Collagen-Carbon Nanotube Composite Biomaterials”
Jan P. Stegemann, Ph.D.
Assistant Professor,
Department of Biomedical Engineering, Rensselaer Polytechnic Institute (Troy, NY)
“Using DNA Self-Assembly to Create Structures with Nanoparticles”
David Keenan
President and CEO, Nanoscience Technologies, Inc. (New York, NY)
Keynote Address #1 - 12:50 p.m. (25 minutes)
“How Nanotech is Changing the World's Industries - Bottom-up Approach in Canada”
Neil Gordon, PEng, MBA
President,
Canadian NanoBusiness Alliance (Montreal, Canada)
Lunch Break: 1:20 p.m. - 2:10 p.m.
Session #2 - 2:10 p.m. – 3:10 p.m. (1 hour)
R&D Innovations in Nanoscience and Nanotechnology
Speakers:
“Nanotechnology Biosensors and Diagnostics”
Steven A. Edwards, Ph.D.
S.A. Edwards & Associates (Christiana, TN)
"Realities of Nanotech Commercialization: Sector By Sector"
Jim Hurd
Director, NanoScience Exchange (San Francisco, CA)
“Atoms Are Amazing!”
Damian Huising '03, MS
Senior Program Administrator,
Rensselaer Nanotechnology Center, Rensselaer Polytechnic Institute (Troy, NY)
"Multifunctional Nanosystems for Targeted Drug and Gene Delivery”
Mansoor M. Amiji, RPh, Ph.D.
Professor and Associate Chair,
Department of Pharmaceutical Sciences, Co-Director, Nanomedicine Education and Research Consortium, Northeastern University (Boston, MA)
Keynote Address #2 - 3:10 p.m. - 3:40 p.m. (25 minutes)
“Nanotechnology and Emerging Environmental Issues”
David P. Flynn, JD
Partner, Environment and Energy Group,
Phillips Lytle LLP (Buffalo, NY)
Break (5 minutes)
Session #3 - 3:45 p.m. (110 minutes)
Panel Discussion: Nanotechnology Policy, Regulatory Trends and Environmental Issues
Panel Moderator:
Charles W. Boylen, Ph.D.
Professor of Biology and
Associate Director, Darrin Fresh Water Institute, Rensselaer Polytechnic Institute (Troy, NY)
Panel Members:
“National Policies to Promote Nanotechnology Commercialization”
Honorable Kelly H. Carnes, JD,
President and CEO, TechVision21 (Washington, DC); Former Assistant Secretary of Commerce for Technology Policy, US Department of Commerce (Washington, DC)
“Industrial Applications of Nanotech for Water, Chemical and Energy Recovery”
John J. Porter, Ph.D.
Emeritus Professor, School of Materials Science and Engineering, Clemson University (Clemson, SC)
“Gap Analysis of Environmental Regulation for Nanotechnology”
Nathan Swami, Ph.D.
Associate Director, NanoQuEST Institute, University of Virginia (Charlottesville, VA)
Ahson Wardak, MS
Senior Associate/Nanotechnology Initiative Coordinator, ENVIRON International Corporation (Arlington, VA)
“FDA Regulatory Approval Issues Regarding Nanotechnology Products”
Mark M. Yacura, JD
Shareholder,
Buchanan Ingersoll & Rooney PC (Washington, DC)
"Regulating Nanotechnology"
Gregory N. Mandel, JD
Associate Dean for Research and Scholarship,
Professor of Law,
Albany Law School (Albany, NY)
“Transhuman and Posthuman Therapeutic Endpoints in Nanomedicine”
Sander Rabin '71, MD, JD
Chairman, Convergent Technology Patent Law Group®, Whiteman Osterman & Hanna LLP (Albany, NY)
"Fourth-Generation Nanotechnology: Disruptive Abundance"
Mike Treder
Executive Director, Center for Responsible Nanotechnology (New York, NY)
“New York and Nanotech: Small Things Creating a Big Future”
John Demarest
Manager, NYSTAR Programs, New York State Office of Science,
Technology and Academic Research (Albany, NY)
Networking Reception 5:35 p.m. - 7:00 p.m.
September 26, 2006 (Tuesday)
On-site Registration and Media Interviews: 9:30 a.m. - 10:00 a.m.
Welcome Remarks - 10:00 a.m.
Jeffrey Schanz
Director,
Office of Alumni Relations and Annual Giving,
Rensselaer Polytechnic Institute (Troy, NY)
Introduction of the Keynote Speaker # 3 - 10:05 a.m.
Keynote Address # 3 - 10:10 a.m. (25 minutes)
“The Medical Device Industry: What Does the Future Hold?”
Joseph D. Bronzino, Ph.D., PE
The Vernon Roosa Professor of Applied Sciences, Trinity College (Hartford, CT);
President, Biomedical Engineering Alliance and Consortium (Hartford, CT)
Session #4 - 10:40 p.m. (1 hour, 15 minutes)
R&D Innovations in Nanomedicine and Nanoscience
Session Chair:
Samuel C. Wait '53, Ph.D.
Acting Dean, School of Science, Professor of Chemistry,
Rensselaer Polytechnic Institute (Troy, NY)
Speakers:
"Use and Characterization of Nanoparticles in the Pharmaceutical Industry"
Roy Haskell, Ph.D.
Research Fellow,
Pharmaceutical Research Institute, Bristol-Myers Squibb, Inc. (Wallingford, CT)
“Peptide Nanotubes: From Medical Hydrogels to Flat Screen TV's”
Assaf Mahler
Laboratory of Professor Ehud Gazit, Department of Molecular Microbiology and Biotechnology, Tel Aviv University (Tel Aviv, Israel)
“Nanoscale Drug Delivery”
Stephen H. Curry, Ph.D.
President, Nanolution Division,
Biophan Technologies, Inc. (West Henrietta, NY)
"Targeted Polymeric Nanoparticles for Cancer Therapy"
Omid C. Farokhzad, MD
Assistant Professor of Anesthesia, Harvard Medical School; Dept of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital (Boston, MA)
"Nanoceramics via Self-assembly with Block Copolymer Ceramic Precursors"
Patrick R. L. Malenfant, Ph.D.
Staff Scientist in the Nanotechnology ATP, GE Global Research (Niskayuna, NY)
Session #5 – 12:00 p.m. (1 hour, 15 minutes)
Nanotechnology Law and Intellectual Property Issues
Speakers:
"Nanotechnology-Related Issues at the US Patent Office"
Bruce M. Kisliuk (invited)
Group Director, Technology Center 1600,
Biotechnology, Pharmaceuticals and Organic Chemistry, US Patent and Trademark Office,
US Department of Commerce (Alexandria, VA)
"IP Due Diligence Issues in Nanotech Start-up Company Investment”
Leon Radomsky, MS, JD
Senior Counsel, Member of Nanotechnology Team, Foley & Lardner LLP (Washington, DC)
“IBM First-of-a-Kind Program”
Marc D. Schechter '75, JD, MBA
Senior Counsel, Intellectual Property Law, IBM Global Business Services, IBM (Somers, NY)
"Patent Strategies for Claiming Nanotech Inventions”
Raj S. Dave, Ph.D., JD
Partner, Morrison & Foerster (McLean, VA)
Lunch Break: 1:15 p.m. - 2:00 p.m.
Keynote Address # 4 - 2:00 p.m. (25 minutes)
“Nucleating Nanotech, Creating a Business from Growing Crystals”
Clinton Ballinger, Ph.D., President and CEO, Evident Technologies, Inc. (Troy, NY)
Session #6 – 2:30 p.m. (1 hour, 15 minutes)
Nanotechnology Business and Commercialization
Speakers:
"Past, Present and Future of Nanotechnology Commercialization”
Michael W. Holman, Ph.D.
Analyst,
Lux Research, Inc. (New York, NY)
“Venture Investing in Nanotechnology”
John A. Cococcia '94
Principal,
FA Technology Ventures (Albany, NY)
“Structuring Collaborative Arrangements in Nanotech - Legal Considerations”
David M. Naseman, JD
Senior Counsel,
Crowell & Moring LLP (Washington, DC)
“Commercializing Nanotechnology: R&D Agreements with Universities”
Michael DeVincenzo, Ph.D., JD
General Counsel/Chief Intellectual Property Counsel, Evident Technologies (Troy, NY)
"Nanotechnology in Singapore"
Teck Thai Heng, MBA
Singapore Economic Development Board (Singapore)
Session #7 - 3:45 p.m. (1 hours)
R&D Innovations in Nanomedicine and Nanoscience
“Drug Resistance and Toxicity Effects of Nanomaterials”
Alok Bhushan, Ph.D.
Associate Professor
James C.K. Lai, Ph.D.
Professor and Assistant Chair
Department of Pharmaceutical Sciences,
College of Pharmacy and Biomedical Research Institute
(Pocatello, ID)
“Nanocomposites and Nanofluids for Thermal Management Applications”
Pawel Keblinski, Ph.D.
Associate Professor of Materials Science and Engineering, Rensselaer Polytechnic Institute (Troy, NY)
"Nano-Delivery in Cystic Fibrosis”
Neeraj Vij, MS, Ph.D.
Research Associate, Division of Respiratory Sciences, Johns Hopkins University School of Medicine (Baltimore, MD)
“Nanotechnology Applied to the Biomedical Sciences”
James N. Turner, Ph.D.
Director, Nanobiotechnology Program; Director, Three-Dimensional Light Microscopy
Wadsworth Center, NYS Department of Health (Albany, NY)
Conclusion of Conference – 4:45 p.m.
Raj Bawa '90, MS, Ph.D.
President, Bawa Biotechnology Consulting, LLC (Ashburn, VA) |